Initially developed for type 2 diabetes, GLP-1RAs have demonstrated robust weight loss in randomized controlled trials and real-world settings, leading to their repositioning as cornerstone obesity treatments ( Human metabolic studies consistently show that reductions in energy intake account for most of the weight loss observed during GLP-1RA therapy, whereas increases in resting energy expenditure are modest or absent ( Beyond total weight loss, the quality of weight loss has become an increasingly important clinical concern
I was an athlete and have continued to be active, swimming, bicycling, walking, playing volleyball, doing Pilates, doing yoga my whole life, and yet my disease of obesity has not been treated until the last two years
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is the copper-bound form of the naturally occurring human tripeptide GHK
Pale yellow urine is a good practical indicator of adequate hydration
In 2023, the inaugural award was presented to Jennifer A